Risk Factors of Neutropenic Enteropathy During Induction Phase of Treatment of Childhood Acute Lymphoblastic Leukemia

被引:0
|
作者
Karim, M. A. [1 ]
Jahan, Y. [1 ]
机构
[1] Bangabandhu Sheikh Mujib Med Univ, Pediat Hematol & Oncol, Dhaka, Bangladesh
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PV0006
引用
收藏
页码:S157 / S157
页数:1
相关论文
共 50 条
  • [31] Prevalence of vitamin D deficiency in childhood acute lymphoblastic leukemia and its association with adverse outcomes during induction phase of treatment
    Bhattacharya, Sudipto
    Verma, Nishant
    Kumar, Archana
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2020, 72 (08): : 1321 - 1325
  • [32] Pentoxifylline during steroid window phase at induction to remission increases apoptosis in childhood with acute lymphoblastic leukemia
    Gonzalez-Ramella, O.
    Ortiz-Lazareno, P. C.
    Jimenez-Lopez, X.
    Gallegos-Castorena, S.
    Hernandez-Flores, G.
    Medina-Barajas, F.
    Meza-Arroyo, J.
    Jave-Suarez, L. F.
    Lerma-Diaz, J. M.
    Sanchez-Zubieta, F.
    Bravo-Cuellar, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (04): : 369 - 374
  • [33] HYPERGLYCEMIA IN ACUTE LYMPHOBLASTIC LEUKEMIA: EVALUATION OF RISK FACTORS FOR INSULIN REQUIREMENT DURING INDUCTION CHEMOTHERAPY
    Pabedinskas, Kristina
    Braschel, Melissa
    Li, Amanda
    Fox, Danya
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 186 - 188
  • [34] Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia
    Seki, Yuko
    Okamoto, Yasuhiro
    Kodama, Yuichi
    Nishikawa, Takuro
    Tanabe, Takayuki
    Nakagawa, Shunsuke
    Mizota, Michiyo
    Kawano, Yoshifumi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (06) : E334 - E337
  • [35] Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia
    Belle, Fabien N.
    Kasteler, Rahel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (08) : 630 - 630
  • [36] ACUTE METABOLIC SIDE EFFECTS OF REMISSION INDUCTION TREATMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Aydogan, M.
    Atasoy, F.
    Tugcu, D.
    Akici, F.
    Salcioglu, Z.
    Akcay, A.
    Sen, H.
    Demirkaya, M.
    Ayaz, N.
    HAEMATOLOGICA, 2012, 97 : 494 - 494
  • [37] Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
    Vrooman, Lynda M.
    Silverman, Lewis B.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (05) : 385 - 394
  • [38] Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
    Lynda M. Vrooman
    Lewis B. Silverman
    Current Hematologic Malignancy Reports, 2016, 11 : 385 - 394
  • [39] Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia
    Thyss, A
    Suciu, S
    Bertrand, Y
    Mazingue, F
    Robert, A
    Vilmer, E
    Mechinaud, F
    Benoit, Y
    Brock, P
    Ferster, A
    Lutz, P
    Boutard, P
    Marguerite, G
    Plouvier, E
    Michel, G
    Plantaz, D
    Munzer, M
    Rialland, X
    Chantraine, JM
    Norton, L
    Solbu, G
    Philippe, N
    Otten, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1824 - 1830
  • [40] Apoptotic cell identification: An in-vivo study during induction treatment of childhood acute lymphoblastic leukemia
    Widjajanto, Pudjo H.
    Veerman, A. J. P.
    Sutaryo
    PAEDIATRICA INDONESIANA, 2006, 46 (9-10) : 195 - 198